PA
IDYA icon

Parallel Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Parallel Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
5,287
+1,318
+33% +$40.3K ﹤0.01% 1294
2026
Q1 		$132K Buy
3,969
+122
+3% +$4.09K ﹤0.01% 1418
2025
Q4 		$133K Buy
3,847
+730
+23% +$23.3K ﹤0.01% 1304
2025
Q3 		$84.8K Sell
3,117
-143
-4% -$3.46K ﹤0.01% 1512
2025
Q2 		$68.5K Buy
3,260
+1,369
+72% +$26.3K ﹤0.01% 1561
2025
Q1 		$31K Buy
1,891
+191
+11% +$4.07K ﹤0.01% 1910
2024
Q4 		$43.7K Sell
1,700
-35
-2% -$991 ﹤0.01% 1707
2024
Q3 		$55K Buy
1,735
+16
+0.9% +$607 ﹤0.01% 1570
2024
Q2 		$60.4K Hold
1,719
– – ﹤0.01% 1428
2024
Q1 		$75.4K Buy
1,719
+1,577
+1,111% +$67.8K ﹤0.01% 1306
2023
Q4 		$5.05K Buy
142
+80
+129% +$2.39K ﹤0.01% 2526
2023
Q3 		$1.67K Hold
62
– – ﹤0.01% 2874
2023
Q2 		$1.46K Sell
62
-26
-30% -$535 ﹤0.01% 2842
2023
Q1 		$1.21K Buy
88
+57
+184% +$950 ﹤0.01% 2914
2022
Q4 		$563 Sell
31
-10
-24% -$168 ﹤0.01% 3019
2022
Q3 		$1K Sell
41
-2
-5% -$26 ﹤0.01% 2930
2022
Q2 		$1K Buy
+43
New +$478 ﹤0.01% 2783
2022
Q1 		– Sell
-12
Closed – – 3098
2021
Q4 		$0 Buy
+12
New +$279 ﹤0.01% 3172

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Parallel Advisors's IDYA Position: Q2 2026 in Review

Parallel Advisors increased its IDEAYA Biosciences (IDYA) stake by 33% in Q2 2026, buying an estimated $40.3K and bringing the position to 5,287 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Parallel Advisors first reported a position in IDYA in Q4 2021 and has held it in 18 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Parallel Advisors held 5,287 shares of IDEAYA Biosciences worth $197K as of Q2 2026.
  • Parallel Advisors bought 1,318 IDEAYA Biosciences shares in Q2 2026, an estimated $40.3K.
  • IDEAYA Biosciences made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1294 holding.
  • Parallel Advisors first reported a position in IDEAYA Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.